About Geneoscopy
Geneoscopy is a company based in St. Louis (United States) founded in 2015.. Geneoscopy has raised $218.95 million across 6 funding rounds from investors including LabCorp, Mercy Health and Bio Rad. Geneoscopy offers products and services including seRNA Technology Platform and Stool-based Screening Test. Geneoscopy operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Personalis, among others.
- Headquarter St. Louis, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Geneoscopy Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$218.95 M (USD)
in 6 rounds
-
Latest Funding Round
$105 M (USD), Series C
Jan 08, 2025
-
Investors
LabCorp
& 16 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Geneoscopy
Geneoscopy offers a comprehensive portfolio of products and services, including seRNA Technology Platform and Stool-based Screening Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Noninvasive platform for detecting colorectal cancer and GI diseases
Test for early detection of gastrointestinal conditions using RNA analysis
Unlock access to complete
Unlock access to complete
Funding Insights of Geneoscopy
Geneoscopy has successfully raised a total of $218.95M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $105 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $105.0M
-
First Round
First Round
(22 Jun 2016)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Series C - Geneoscopy | Valuation | Bio Rad | |
| Nov, 2021 | Amount | Series B - Geneoscopy | Valuation | LightChain Capital , NT Investments | |
| Nov, 2021 | Amount | Debt – Conventional - Geneoscopy | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Geneoscopy
Geneoscopy has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include LabCorp, Mercy Health and Bio Rad. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Petrichor is engaged in supporting healthcare innovation through investments.
|
Founded Year | Domain | Location | |
|
Multiple sectors are invested in by Morningside, a VC fund.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on early-stage life science companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Geneoscopy
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Geneoscopy
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Geneoscopy Comparisons
Competitors of Geneoscopy
Geneoscopy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Personalis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Geneoscopy
Frequently Asked Questions about Geneoscopy
When was Geneoscopy founded?
Geneoscopy was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Geneoscopy located?
Geneoscopy is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Is Geneoscopy a funded company?
Geneoscopy is a funded company, having raised a total of $218.95M across 6 funding rounds to date. The company's 1st funding round was a Series B of $105M, raised on Jun 22, 2016.
What does Geneoscopy do?
Geneoscopy was founded in 2015 and is headquartered in St. Louis, United States. Non-invasive diagnostic tests for colorectal cancer are developed within the biotechnology sector. Stool samples are examined for a panel of mRNA biomarkers through a proprietary algorithm to identify the disease. The primary assay is designed for screening patients potentially needing colonoscopy procedures, with operations centered on advancing biomarker-based diagnostics.
Who are the top competitors of Geneoscopy?
Geneoscopy's top competitors include Juno Therapeutics, Personalis and Poseida Therapeutics.
What products or services does Geneoscopy offer?
Geneoscopy offers seRNA Technology Platform and Stool-based Screening Test.
Who are Geneoscopy's investors?
Geneoscopy has 17 investors. Key investors include LabCorp, Mercy Health, Bio Rad, Arch Grants, and Petrichor.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.